Skip to Content

Proposed Rule

Sunscreen Drug Products for Over-the-Counter Human Use; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a proposed rule relating to the regulation of over-the-counter (OTC) sunscreen monograph products that appeared in the Federal Register of February 26, 2019. The document was published with formulas that were illegible. These corrections are being made to improve the accuracy of the proposed rule.

DATES:

Submit either electronic or written comments on the proposed rule by June 27, 2019.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Kristen Hardin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5443, Silver Spring, MD 20993, 240-402-4246.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of February 26, 2019 (84 FR 6204), in FR Doc. 2019-03019, on pages 6267 through 6270, the following corrections are made:

1. On page 6267, in the first column, the formula under § 201.327(i)(2)(ii)(B) is corrected to read:

Start Printed Page 16221

2. On page 6268, in the second column, the formula under § 201.327(i)(3)(ii)(C)(2) is corrected to read:

3. On page 6268, in the second column, the formulas under § 201.327(i)(3)(ii)(D)(2)(i) are corrected to read:

4. On page 6269, in the third column, the formula under § 201.327(i)(7)(i) is corrected to read:

5. On page 6269, in the third column, the formulas under § 201.327(i)(7)(ii) are corrected to read:

6. On page 6270, in the second column, the formula under § 201.327(j)(4)(ii) is corrected to read:

7. On page 6270, in the third column, the formulas under § 201.327(j)(5)(i) are corrected to read:

Start Printed Page 16222

8. On page 6270, in the third column, the formula under § 201.327(j)(7) is corrected to read:

9. On page 6270, in the third column, the formula under § 201.327(j)(8) is corrected to read:

Elsewhere in this issue of the Federal Register, FDA is extending the comment period on the proposed rule.

Start Signature

Dated: April 12, 2019.

Lowell J. Schiller,

Principal Associate Commissioner for Policy.

End Signature End Supplemental Information

BILLING CODE 4164-01-P

[FR Doc. 2019-07712 Filed 4-17-19; 8:45 am]

BILLING CODE 4164-01-C